Integrated Investment Consultants’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $207K | Hold |
945
| – | – | 0.04% | 305 |
|
|
2025
Q1 | $212K | Sell |
945
-2
| -0.2% | -$448 | 0.04% | 303 |
|
|
2024
Q4 | $310K | Hold |
947
| – | – | 0.06% | 226 |
|
|
2024
Q3 | $284K | Sell |
947
-10
| -1% | -$3K | 0.06% | 242 |
|
|
2024
Q2 | $379K | Hold |
957
| – | – | 0.1% | 170 |
|
|
2024
Q1 | $379K | Sell |
957
-6
| -0.6% | -$2.37K | 0.1% | 170 |
|
|
2023
Q4 | $339K | Buy |
963
+2
| +0.2% | +$704 | 0.11% | 170 |
|
|
2023
Q3 | $361K | Sell |
961
-16
| -2% | -$6K | 0.13% | 138 |
|
|
2023
Q2 | $374K | Sell |
977
-9
| -0.9% | -$3.44K | 0.12% | 152 |
|
|
2023
Q1 | $342K | Buy |
986
+11
| +1% | +$3.81K | 0.11% | 171 |
|
|
2022
Q4 | $229K | Buy |
975
+13
| +1% | +$3.06K | 0.08% | 214 |
|
|
2022
Q3 | $237K | Sell |
962
-4
| -0.4% | -$985 | 0.09% | 185 |
|
|
2022
Q2 | $292K | Hold |
966
| – | – | 0.11% | 163 |
|
|
2022
Q1 | $397K | Sell |
966
-26
| -3% | -$10.7K | 0.11% | 169 |
|
|
2021
Q4 | $465K | Buy |
992
+5
| +0.5% | +$2.34K | 0.12% | 144 |
|
|
2021
Q3 | $419K | Buy |
987
+13
| +1% | +$5.52K | 0.12% | 154 |
|
|
2021
Q2 | $350K | Hold |
974
| – | – | 0.1% | 190 |
|
|
2021
Q1 | $274K | Hold |
974
| – | – | 0.09% | 197 |
|
|
2020
Q4 | $276K | Hold |
974
| – | – | 0.1% | 184 |
|
|
2020
Q3 | $268K | Sell |
974
-254
| -21% | -$69.9K | 0.13% | 146 |
|
|
2020
Q2 | $279K | Buy |
+1,228
| New | +$279K | 0.13% | 115 |
|
|
2018
Q4 | – | Sell |
-1,916
| Closed | -$237K | – | 187 |
|
|
2018
Q3 | $237K | Buy |
+1,916
| New | +$237K | 0.12% | 139 |
|
|
2018
Q2 | – | Sell |
-1,565
| Closed | -$138K | – | 711 |
|
|
2018
Q1 | $138K | Buy |
+1,565
| New | +$138K | 0.05% | 251 |
|
|
2017
Q3 | $108K | Buy |
1,123
+270
| +32% | +$26K | 0.05% | 281 |
|
|
2017
Q2 | $81K | Buy |
+853
| New | +$81K | 0.04% | 331 |
|